AI-Designed Drug Rentosertib Shows Early Signs of Slowing Biological Aging in Lung Disease Trial
Covered by 2 sources
Insilico Medicine developed rentosertib using AI to treat a rare lung disease; early trial data from 42 patients indicates the drug may reduce biological age markers by several years, though the cause remains unclear.